Physician profile
Katia Castillo
NPI 1598759110
$1,653.25
in general payments reported to CMS, 2019-2025
26 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $66.52 · 2021: $319 · 2022: $361 · 2023: $183 · 2024: $139 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $310.33 | 2021-2023 | Liletta |
| Therapeuticsmd, INC. | $201.44 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $139.77 | 2022-2024 | |
| Exeltis, USA INC. | $136.67 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $112.27 | 2023-2025 | Veozah |
| Organon LLC | $91.41 | 2022-2025 | Jada System, Nexplanon |
| Agile Therapeutics, INC. | $90.96 | 2021-2022 | |
| Hologic Sales and Service, LLC | $53.65 | 2019-2021 | |
| Scynexis, INC. | $51.78 | 2022 | |
| Avion Pharmaceuticals | $48.65 | 2019-2022 | |
| Coopersurgical, INC. | $46.50 | 2020-2024 | Paragard T 380a |
| Optumhealth Care Solutions, LLC | $46.29 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Lupin INC. | $44.19 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $39.07 | 2019-2021 | |
| Novum Pharma, LLC | $29.84 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $28.38 | 2019 | |
| Baxter Healthcare | $24.37 | 2023 | Tisseel |
| Pfizer INC. | $22.84 | 2025 | |
| Dexcom, INC. | $22.72 | 2025 | Dexcom G6 Transmitter |
| Evofem Biosciences, INC. | $18.88 | 2023 | Phexxi |
| Millicent US INC | $18.63 | 2025 | Intrarosa, Femlyv |
| Davol INC. | $18.01 | 2021 | |
| Aspira Women'S Health INC | $17.54 | 2022 | |
| Allergan, INC. | $15.20 | 2019 | |
| Becton, Dickinson and Company | $12.33 | 2022 | |
| Merck Sharp & Dohme LLC | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katia Castillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.